Location History:
- Lingolsheim, FR (2018 - 2021)
- Ways, BE (2022)
Company Filing History:
Years Active: 2018-2022
Title: Innovations by Baptiste Manteau: A Pillar in Metabotropic Glutamate Receptor Modulation
Introduction: Baptiste Manteau, a prominent inventor based in Lingolsheim, France, has made significant strides in the field of pharmaceutical compositions and neurological treatments. With an impressive portfolio of five patents, Manteau focuses on novel compounds that modulate glutamatergic signaling, a crucial area in addressing various neurological and psychiatric disorders.
Latest Patents: Manteau's latest innovations include the following patents:
1. **Substituted Heterocyclic Compounds as Allosteric Modulators of Group II Metabotropic Glutamate Receptors:** This invention presents novel heterocyclic compounds that serve as pharmaceutical compositions for treating conditions related to altered glutamatergic signaling. The compounds aim to modulate nervous system receptors sensitive to glutamate, thereby offering potential therapeutic benefits for neurological and psychiatric disorders.
2. **Substituted Tricyclic 1,4-Benzodiazepinone Derivatives as Allosteric Modulators of Group II Metabotropic Glutamate Receptors:** In a similar vein, this patent highlights tricyclic 1,4-benzodiazepinone derivatives that also act as modulators of metabotropic glutamate receptors. Designed for treating conditions associated with glutamate signaling alterations, these compounds represent a promising area in neurological treatment.
Career Highlights: Baptiste Manteau has played a pivotal role in the research and development landscape through his work with notable companies. His experience includes significant contributions at Domain Therapeutics and Prexton Therapeutics, both of which are renowned for their innovative approaches in drug development. Manteau’s insights and expertise in glutamatergic modulation have positioned him as a key contributor in pharmaceutical breakthroughs.
Collaborations: Throughout his career, Manteau has collaborated with esteemed colleagues such as Stephan Schann and Stanislas Mayer. These collaborations have fostered a multidisciplinary approach to research, enhancing the depth and breadth of their innovative efforts in the realm of neuroscience.
Conclusion: Baptiste Manteau's contributions to the field of pharmaceutical chemistry and glutamatergic signaling modulation underscore his importance as an inventor. With his ongoing research and development efforts, Manteau continues to pave the way for new therapeutic avenues that could significantly impact the treatment of neurological and psychiatric disorders. His patentsnot only highlight his innovative prowess but also reflect a commitment to improving health outcomes through scientific advancement.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.